報價延遲最少15分鐘:2024/05/05 16:13 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
72.85 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.07/2.65
|
|
企業價值
114.84B
|
| 資產負債 |
|
每股賬面淨值
13.12
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
14.24B
|
|
每股收益
9.36
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/05/05 16:13 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. |